Avid Bioservices Inc (CDMO)

[pphmtoolong]

chenzo11, you are probably right. With the reverse split hanging over our heads, it's hard to see how the SP can move up appreciably. The "however" is that Avid future profitability may support a market capitalization well above our current 100 million or so. This is certainly not a stretch when Peregrine is sitting on more than 50 million. So, buying here would take guts, but has a good chance to be profitable in a year or two.

Of course in the unlikely event that Bavi-immunotherapy actually is worth something, the SP could move much higher.

The game has changed. We are not looking at a short term big winner. We may be looking at a relatively near term solid winner. We may be looking at a mid to long term big winner. We'll see.

GLTA, Paul